Exponent, Inc. - Common Stock (NQ:EXPO)

77.57 +0.14 (+0.18%)

Delayed Quote Updated: 11:31 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exponent, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

3 Profitable Stocks We’re Skeptical Of

October 27, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Independent Investment Manager Sells $24.6 Million of Exponent Stock, According to Recent Filing ↗

October 26, 2025

Independent Investment Manager Sells $24.6 Million of Exponent Stock, According to Recent Filing

Via The Motley Fool

Topics Regulatory Compliance

Exponent to Announce Third Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on October 30, 2025

October 09, 2025

From Exponent, Inc.

Via GlobeNewswire

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

1 High-Flying Stock to Target This Week and 2 We Ignore

October 08, 2025

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly...

Via StockStory

Topics Emissions

1 Services Stock for Long-Term Investors and 2 That Underwhelm

September 24, 2025

Business services providers play a critical role for enterprises, assisting them with everything from new hardware integrations to consulting and marketing. Furthermore, the demand for their offerings...

Via StockStory

Topics Stocks

3 Small-Cap Stocks That Fall Short

September 16, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

1 Oversold Stock Ready to Bounce Back and 2 We Brush Off

August 22, 2025

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value...

Via StockStory

Winners And Losers Of Q2: Exponent (NASDAQ:EXPO) Vs The Rest Of The Business Process Outsourcing & Consulting Stocks

August 19, 2025

Let’s dig into the relative performance of Exponent (NASDAQ:EXPO) and its peers as we unravel the now-completed Q2 business process outsourcing & consulting earnings season.

Via StockStory

Topics Artificial Intelligence Economy

2 Cash-Heavy Stocks Worth Investigating and 1 We Ignore

August 14, 2025

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

Via StockStory

EXPO Q2 Deep Dive: Litigation Demand Offsets Flat Revenue, Margin Compression Persists

August 12, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) beat Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $132.9 million. On the other hand, next quarter’s revenue...

Via StockStory

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks with Open Questions

August 04, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Exponent (EXPO) Q2 Revenue Rises 1% ↗

August 01, 2025

Via The Motley Fool

Topics Artificial Intelligence Product Recall

CDW, CRA, Crane NXT, Diebold Nixdorf, and Exponent Shares Are Falling, What You Need To Know

August 01, 2025

A number of stocks fell in the morning session after a surprisingly weak U.S. jobs report was released, fueling concerns about a slowing economy.

Via StockStory

Topics Artificial Intelligence Economy

Exponent’s (NASDAQ:EXPO) Q2: Beats On Revenue But Quarterly Revenue Guidance Slightly Misses Expectations

July 31, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 7.2% year on year to $142 million. On the other hand, next...

Via StockStory

Exponent Inc (NASDAQ:EXPO) Delivers Mixed Q2 2025 Results with EPS Beat and Revenue Miss, Market Reaction Neutral ↗

July 31, 2025

Exponent Inc (NASDAQ:EXPO) reported mixed Q2 2025 results, with EPS beating estimates but revenue slightly missing. Shares remained flat post-earnings, reflecting neutral investor sentiment. The...

Via Chartmill

Exponent Declares Regular Quarterly Dividend for Q3 2025

July 31, 2025

From Exponent, Inc.

Via GlobeNewswire

Exponent Reports Second Quarter 2025 Financial Results

July 31, 2025

From Exponent, Inc.

Via GlobeNewswire

Exponent Inc (NASDAQ:EXPO) Stands Out as a High-Quality Pick Under the Caviar Cruise Strategy ↗

July 31, 2025

Exponent Inc (EXPO) excels with high profitability, strong cash flow, and steady growth, making it a top pick for long-term quality investors under the Caviar Cruise strategy.

Via Chartmill

Exponent (EXPO) Reports Earnings Tomorrow: What To Expect

July 29, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) will be reporting earnings this Thursday afternoon. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

2 High-Flying Stocks to Target This Week and 1 to Avoid

July 11, 2025

Via StockStory

Exponent to Announce Second Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on July 31, 2025

July 10, 2025

From Exponent, Inc.

Via GlobeNewswire

1 Small-Cap Stock with Competitive Advantages and 2 to Be Wary Of

June 23, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Business Process Outsourcing & Consulting Stocks Q1 Teardown: Exponent (NASDAQ:EXPO) Vs The Rest

June 15, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how business process outsourcing & consulting stocks fared in Q1,...

Via StockStory

Topics Artificial Intelligence Economy

3 Low-Volatility Stocks with Questionable Fundamentals

June 09, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

3 Out-of-Favor Stocks Skating on Thin Ice

June 06, 2025

Via StockStory

EXPO Q1 Earnings Call: Resilient Results as Macro Uncertainty Impacts Guidance

May 15, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $137.4 million. On the other hand, next quarter’s revenue...

Via StockStory

3 High-Flying Stocks with Questionable Fundamentals

May 13, 2025

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

Via StockStory

Exponent (NASDAQ:EXPO) Surprises With Q1 Sales But Quarterly Revenue Guidance Significantly Misses Expectations

May 01, 2025

Scientific consulting firm Exponent (NASDAQ:EXPO) announced better-than-expected revenue in Q1 CY2025, with sales up 6% year on year to $145.5 million. On the other hand, next quarter’s revenue...

Via StockStory

Exponent Reports First Quarter 2025 Financial Results

May 01, 2025

From Exponent, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.